Author: Anna Smith

Eli Lilly to buy Loxo Oncology for $8 billion

Eli Lilly has announced its intention to buy pioneering cancer treatment development company Loxo Oncology in a deal worth approximately $8 billion.

Takeda completes Shire acquisition

Takeda has completed its £46-billion acquisition of Shire, a deal that took just eight months to see through from announcement to close.

Daiichi & Esperion agreement for Bempedoic Acid

Daiichi Sankyo Europe has entered into a European licensing agreement with Esperion for bempedoic acid, and the bempedoic acid/ezetimibe combination tablet.

NHS Long Term Plan to save up to 500,000 lives

Long-awaited details of the NHS Long Term Plan, which is to be funded by a government investment of £20.5 billion a year in real terms by 2023/24 – have now been unveiled, with the promise of saving almost half a million more lives.

Janssen files Stelara in Europe for ulcerative colitis

Janssen has submitted an application to the European Medicines Agency (EMA) seeking to expand the approval of Stelara to include the treatment of adults with moderately to severely active ulcerative colitis (UC).